Can we improve the results of simultaneous pancreas-kidney transplantation?
Fornairon
S
S
Department of Nephrology, Hospital Saint-Louis, Paris, France.
Desgrandchamps
F
F
Cattan
P
P
Meria
P
P
Anidjar
M
M
Bedrossian
J
J
Teillac
P
P
Le Duc
A
A
Legendre
C
C
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods; D010179:Pancreas; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus